Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: growthvalue who wrote (23762)	7/31/1998 8:00:00 PM
From: RevMikeB	Read Replies (1) \| Respond to of 32384

<<While a good phase II in a big indication can certainly be a positive, (so if LGND has some good data for Targretin oral in type II diabetes, that could be a relatively modest boost) it's just not the kind of Mark McGwire home run you get when you get a wildly positive phase III in a big indication.>> I'd take any boost in this stock at this point. Growthvalue, I appreciate your comments. Please keep posting. By the way, since you mentioned all the different factors for valuing Biotechs and you are investing in LGND because you think it's cap might grow to billions, what do you think the earnings will be over the next 5 years or more? Where do you see this stock over that time frame?